NANOVIRICIDES, INC. Debt Conversion, Original Debt, Amount
NANOVIRICIDES, INC. (NNVC) reported Debt Conversion, Original Debt, Amount of $0 for the 9-month period ending 2018-03-31, per its 10-Q filed 2018-05-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2019-08-23
- 2018-03-31: Debt Conversion, Original Debt, Amount 9 month $0.00.
- 2017-03-31: Debt Conversion, Original Debt, Amount 9 month $5.00M.
- 2017-02-08: Debt Conversion, Original Debt, Amount 0 month $5.33M; Debt Conversion, Original Debt, Amount 1 month $5.33M.
| Period end | Debt Conversion, Original Debt, Amount 0 month | Debt Conversion, Original Debt, Amount 1 month | Debt Conversion, Original Debt, Amount 9 month |
|---|---|---|---|
| 2018-03-31 | $0.00 10-Q · filed 2018-05-21 | ||
| 2017-03-31 | $5.00M 10-Q · filed 2018-05-21 | ||
| 2017-02-08 | $5.33M 10-Q · filed 2017-05-15 | $5.33M 10-K · filed 2019-08-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |